University at Buffalo: Study - 'Hexaplex' Vaccine Aims to Boost Flu Protection
February 24, 2024
February 24, 2024
BUFFALO, New York, Feb. 24 (TNSres) -- The University at Buffalo (State University of New York) issued the following news release:
* * *
Tests show the recombinant vaccine outperforming existing vaccines in some areas
* * *
Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.
They're easy to precisely produce. They're safe, and potentially more effective . . .
* * *
Tests show the recombinant vaccine outperforming existing vaccines in some areas
* * *
Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.
They're easy to precisely produce. They're safe, and potentially more effective . . .